The Study of Biodistribution and Dosimetry of 99mTc-Glycopeptide(99mTc-GP) in Patients With Breast Cancer
Phase 1
- Conditions
- Breast Cancer
- Interventions
- Radiation: Radiolabeled (99mTc) GP (Glycopeptide)
- First Posted Date
- 2010-07-09
- Last Posted Date
- 2014-07-30
- Lead Sponsor
- SeeCure LLC
- Target Recruit Count
- 9
- Registration Number
- NCT01159405
- Locations
- 🇺🇸
Houston Methodist Hospital, Houston, Texas, United States
© Copyright 2025. All Rights Reserved by MedPath